Danziten Prices, Coupons, Copay Cards & Patient Assistance
Danziten (nilotinib) is a member of the BCR-ABL tyrosine kinase inhibitors drug class and is commonly used for Chronic Myelogenous Leukemia.
The cost for Danziten 71 mg oral tablet is around $19,252 for a supply of 112 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Danziten is available as a brand name drug only, a generic version is not yet available. View generic Danziten availability for more details.
Danziten prices
Oral Tablet
71 mg
Danziten oral tablet
from $19,252.05
for 112 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 112 (4 x 28 each) | $171.89 | $19,252.05 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
95 mg
Danziten oral tablet
from $19,252.05
for 112 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 112 (4 x 28 each) | $171.89 | $19,252.05 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Danziten Coupons, Copay Cards and Rebates
Danziten offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Danziten Connect Co-Pay Program
Eligible commercially insured patients may pay as little as $0 each month.
- Applies to:
- Danziten
- Number of uses:
- Per length of program
Form more information phone: 888-215-8350 or Visit website
Danziten First Free Month Offer
Eligible patients may receive their first month free, without using insurance.
- Applies to:
- Danziten
- Number of uses:
- 1 time
Form more information phone: 877657761 or Visit website
Patient Assistance & Copay Programs for Danziten
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Danziten (nilotinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Danziten CONNECT
Eligibility requirements:- Must be uninsured or underinsured
- Not disclosed
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Co‑payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Danziten (nilotinib) Tablet
More information please phone: 877-765-1130 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
More about Danziten (nilotinib)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
